US FDA grants Orphan Drug Designation to Adolore BioTherapeutics’ Kv7-activating rdHSV-CA8 therapy to treat erythromelalgia: Delray Beach, Florida Friday, January 16, 2026, 17:0 ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to hereditary neuronal sodium ion channel mutationsAdolore's Kv7 voltage-gated po ...

Eli Lilly has built the case for its oral GLP-1 agonist orforglipron with two more phase 3 readouts, including new data showing that it can improve blood glucose compared to a go-to therapy for type 2 ...

SME IPO: The initial public offering (IPO) of EPW India opened today, December 22, for bidding. The SME IPO will remain open till Wednesday, December 24. EPW India operates in the refurbished IT ...

Digital health company Noom has started offering lower doses of GLP-1 agonist semaglutide, the active ingredient in Novo Nordisk's weight-loss drug Wegovy, at a knock-down price. The 'microdose' ...

In some studies, half of patients stopped taking GLP-1s within a year despite the benefits, citing the expense and side effects. By Paula Span Year after year, Mary Bucklew strategized with a ...

Gujarat Kidney IPO Day 3: Today is the last day to subscribe to the initial public offering (IPO) of Gujarat Kidney & Super Speciality. The mainboard public offering, which opened on December 22, has ...

Please provide your email address to receive an email when new articles are posted on . Oral semaglutide 25 mg is a once-daily medication approved to reduce body weight for adults with overweight or ...

The Food and Drug Administration on Monday approved a pill version of Wegovy, Novo Nordisk’s blockbuster weight loss drug. The Wegovy pill, as it’s called, is first oral version of a GLP-1 drug that ...

KSH International initial public offering (IPO) grey market premium (GMP) is trading flat a day ahead of its listing on the exchanges on December 23. According to platforms tracking grey market ...

Amber Carter had battled with her weight for as long as she could remember. For decades, the 39-year-old from Clarkston, Michigan, had been caught in a frustrating cycle: eating a balanced diet, ...